Meeting Abstract RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- Investigating the role of B cell signaling in atherosclerosis
- IOPS-Guided Antegrade In-Situ Laser Fenestration in an Aortic Model
- IS ANTI-NXP2 AUTOANTIBODY A RISK FACTOR FOR CALCINOSIS AND POOR OUTCOME IN JUVENILE DERMATOMYOSITIS PATIENTS?
- IS EPWORTH SLEEPINESS SCORE RELIABLE AS A SCREENING TOOL FOR OSA?
- IS IT TIME TO STOP PERFORMING ROUTINE ENDOSCOPIC SPHINCTEROTOMIES WHEN PLACING BILIARY STENTS? A SYSTEMATIC REVIEW AND META-ANALYSIS
- Is It Worth It? Distal Revascularization and Interval Ligation for Management of Dialysis Access Steal Syndrome
- Is There Ever an Indication for Hormone Therapy in an Asymptomatic Postmenopausal Woman?
- IS THICKER BETTER? ENDOMETRIAL THICKNESS AT THE TIME OF INTRAUTERINE INSEMINATION.
- ISOLATED AMYLOIDOMA OF THE LUNG
- Isthmocele repair: a combined hysteroscopic and laparoscopic approach
- IVF program success influenced by variability in day 3 embryo grading.
- Just-In-Time Emergency Refresher Tool for Transvenous Pacemaker Placement Increases Performance
- Key efficacy and safety of apremilast in patients with mild to moderate plaque psoriasis in the phase 3 ADVANCE trial
- Khorana Risk Score for Thrombosis Prediction in Patients with Gynecologic Malignancies Using Immune Checkpoint Inhibitors- a Real-World Validation
- Kinetic Characterization of the Mitochondrial Transporter Human Myosin XIX
- Labor patterns do not predict complications in patients with vaginal birth after cesarean
- Lack of diversity in hidradenitis suppurativa clinical trials: A cross-sectional analysis
- Lacritin, a Novel Tear Glycoprotein, is an Effective Topical Treatment in Dry Eye Animal Models
- Lacritin, a Novel Tear Glycoprotein, Stimulates Tear Production in Rabbits without Ocular Toxicity
- Language Variant of Atypical Alzheimer's Disease: A Case Study
- Lanreotide Depot/Autogel for Symptomatic Control of Carcinoid Syndrome (CS) in Patients With Neuroendocrine Tumors (NETs) Previously Responsive to Octreotide: Subanalysis of Patient-Reported Symptoms From the Phase 3 ELECT Study
- Lanreotide for the Prolonged Control of Carcinoid Syndrome (CS) in Somatostatin Analog (SSA)-Naive or -Experienced Patients
- Lanreotide for the Prolonged Control of Carcinoid Syndrome (CS) in Somatostatin Analog (SSA)-Naive or -Experienced Patients
- Laparoscopic myomectomy: when and how?
- Laparoscopic Two-Port Myomectomy-a Retrospective Case Series of a Novel Minimally Invasive Approach
- Laparotomy after completion of primary cesarean delivery-a case: control study
- LASER-ASSISTED HATCHING (LAH) OF CRYOPRESERVED EMBRYOS - THE SIGNIFICANCE OF HOLE SIZE.
- Late Breaking Abstract - Add-on mepolizumab for chronic rhinosinusitis with nasal polyps: SYNAPSE study
- Late Breaking Abstract - Response to mepolizumab in patients with severe CRSwNP using EUFOREA 2021 criteria
- Leadership, Teamwork, and Health Care Economics Training in Surgical and Procedural Specialties: Where Does Vascular Surgery Stand?